The intratumoral estrogen disposition in breast cancer is probably predominantly dependent on uptake of estrogens from the circulation and binding to the ER [32], while additional factors like the intra-tumor aromatase activity may contribute to the final concentration of intra-tumor estrogens in ER-positive breast cancer as well [33] among other factors. This evidence concerns the gene CYP19A1 and neoplasm.